These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 19004604)

  • 1. Nedd4L expression is downregulated in prostate cancer compared to benign prostatic hyperplasia.
    Hu XY; Xu YM; Fu Q; Yu JJ; Huang J
    Eur J Surg Oncol; 2009 May; 35(5):527-31. PubMed ID: 19004604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lower levels of nuclear beta-catenin predict for a poorer prognosis in localized prostate cancer.
    Horvath LG; Henshall SM; Lee CS; Kench JG; Golovsky D; Brenner PC; O'Neill GF; Kooner R; Stricker PD; Grygiel JJ; Sutherland RL
    Int J Cancer; 2005 Jan; 113(3):415-22. PubMed ID: 15455387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PPM1D as a novel biomarker for prostate cancer after radical prostatectomy.
    Jiao L; Shen D; Liu G; Jia J; Geng J; Wang H; Sun Y
    Anticancer Res; 2014 Jun; 34(6):2919-25. PubMed ID: 24922655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical expression of interleukin-2 receptor and interleukin-6 in patients with prostate cancer and benign prostatic hyperplasia: association with asymptomatic inflammatory prostatitis NIH category IV.
    Engelhardt PF; Seklehner S; Brustmann H; Lusuardi L; Riedl CR
    Scand J Urol; 2015 Apr; 49(2):120-6. PubMed ID: 25363611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression levels of heat shock protein 27 and cellular FLICE-like inhibitory protein in prostate cancer correlate with Gleason score sum and pathologic stage.
    Lee SW; Cho JM; Cho HJ; Kang JY; Kim EK; Yoo TK
    Korean J Urol; 2015 Jul; 56(7):505-14. PubMed ID: 26175869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcription alterations of members of the ubiquitin-proteasome network in prostate carcinoma.
    Hellwinkel OJ; Asong LE; Rogmann JP; Sültmann H; Wagner C; Schlomm T; Eichelberg C
    Prostate Cancer Prostatic Dis; 2011 Mar; 14(1):38-45. PubMed ID: 21102547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor beta 1 and androgen receptors in prostate neoplasia.
    Cardillo MR; Petrangeli E; Salvatori L; Ravenna L; Di Silverio F
    Anal Quant Cytol Histol; 2000 Oct; 22(5):403-10. PubMed ID: 11064817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of Nedd4L is associated with the aggressive progression and worse prognosis of malignant glioma.
    He S; Deng J; Li G; Wang B; Cao Y; Tu Y
    Jpn J Clin Oncol; 2012 Mar; 42(3):196-201. PubMed ID: 22217575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene expression profiles of lysophosphatidic acid-related molecules in the prostate: relevance to prostate cancer and benign hyperplasia.
    Zeng Y; Kakehi Y; Nouh MA; Tsunemori H; Sugimoto M; Wu XX
    Prostate; 2009 Feb; 69(3):283-92. PubMed ID: 19025891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SMARCC1 expression is upregulated in prostate cancer and positively correlated with tumour recurrence and dedifferentiation.
    Heebøll S; Borre M; Ottosen PD; Andersen CL; Mansilla F; Dyrskjøt L; Orntoft TF; Tørring N
    Histol Histopathol; 2008 Sep; 23(9):1069-76. PubMed ID: 18581278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of NKX3.1 expression in prostate cancer tissues and correlation with clinicopathologic features.
    Aslan G; Irer B; Tuna B; Yorukoglu K; Saatcioglu F; Celebi I
    Pathol Res Pract; 2006; 202(2):93-8. PubMed ID: 16413692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of BMP2, Smad8, and Smad4 expression in prostate cancer progression.
    Horvath LG; Henshall SM; Kench JG; Turner JJ; Golovsky D; Brenner PC; O'Neill GF; Kooner R; Stricker PD; Grygiel JJ; Sutherland RL
    Prostate; 2004 May; 59(3):234-42. PubMed ID: 15042598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of estrogen receptor β and Ki 67 in benign & malignant human prostate lesions by immunohistochemistry.
    Grover SK; Agarwal S; Gupta S; Wadhwa N; Sharma N
    Pathol Oncol Res; 2015 Jul; 21(3):651-7. PubMed ID: 25527409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of mRNA, Protein, and Urinary Nucleic Acid Levels of S100A8 and S100A9 between Prostate Cancer and BPH.
    Yun SJ; Yan C; Jeong P; Kang HW; Kim YH; Kim EA; Lee OJ; Kim WT; Moon SK; Kim IY; Choi YH; Kim WJ
    Ann Surg Oncol; 2015 Jul; 22(7):2439-45. PubMed ID: 25348783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of tissue and circulating levels of IMP3 in prostate cancer.
    Szarvas T; Tschirdewahn S; Niedworok C; Kramer G; Sevcenco S; Reis H; Shariat SF; Rübben H; vom Dorp F
    Int J Cancer; 2014 Oct; 135(7):1596-604. PubMed ID: 24615121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increase of AKT/PKB expression correlates with gleason pattern in human prostate cancer.
    Liao Y; Grobholz R; Abel U; Trojan L; Michel MS; Angel P; Mayer D
    Int J Cancer; 2003 Nov; 107(4):676-80. PubMed ID: 14520710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased RECK expression indicating proteolytic imbalance in prostate cancer is associated with higher tumor aggressiveness and risk of prostate-specific antigen relapse after radical prostatectomy.
    Rabien A; Burkhardt M; Jung M; Fritzsche F; Ringsdorf M; Schicktanz H; Loening SA; Kristiansen G; Jung K
    Eur Urol; 2007 May; 51(5):1259-66. PubMed ID: 16806661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of her-2/neu in human prostate cancer and benign hyperplasia.
    Gu K; Mes-Masson AM; Gauthier J; Saad F
    Cancer Lett; 1996 Feb; 99(2):185-9. PubMed ID: 8616823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ghrelin receptor as a novel imaging target for prostatic neoplasms.
    Lu C; McFarland MS; Nesbitt RL; Williams AK; Chan S; Gomez-Lemus J; Autran-Gomez AM; Al-Zahrani A; Chin JL; Izawa JI; Luyt LG; Lewis JD
    Prostate; 2012 Jun; 72(8):825-33. PubMed ID: 21919027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue expression of transforming growth factor-beta1 and its receptors: correlation with pathologic features and biochemical progression in patients undergoing radical prostatectomy.
    Shariat SF; Menesses-Diaz A; Kim IY; Muramoto M; Wheeler TM; Slawin KM
    Urology; 2004 Jun; 63(6):1191-7. PubMed ID: 15183988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.